Study finds remdesivir and hydroxychloroquine have little impact on mortality in COVID-19 patients

PHOTO CREDITS: STAT A clinical trial conducted by the World Health Organization found that Gilead Sciences Inc.’s remdesivir, hydroxychloroquine, AbbVie’s ABBV Lopinavir/ritonavir, and interferon did not impact mortality among hospitalized COVID-19 patients.  The study was first reported by the Financial Times on Thursday. In a pre-print, which is medical research[Read More…]

Oxford scientists develop COVID-19 test that delivers results in less than five minutes

PHOTO CREDITS: GREENSBORO NEWS AND RECORD  Scientists from Oxford University’s Department of Physics have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes.  The researchers hoped that the test could eventually be used at airports, music venues, gyms, and businesses to quickly establish[Read More…]